Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood-derived face cream boosts skin moisture and elasticity in small trial

NCT ID NCT07359924

Symptom relief Sponsor: Poznan University of Medical Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a face cream containing platelet-rich fibrin (PRF), made from a person's own blood, to see if it could improve skin aging. Twenty healthy adults aged 20-40 applied three different creams to their faces daily for four weeks. The PRF cream improved skin hydration, elasticity, and barrier function more than a plain cream or one with added growth factor. The results suggest PRF creams are safe and effective, but larger and longer studies are needed.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
platelet-rich fibrin (PRF) cream
What this could lead to
If it works, this could lead to a natural, safe anti-aging cream that improves skin hydration and elasticity without harsh chemicals.
What could go wrong
This was a small, short-term study on 20 healthy people, so results may not apply to everyone. The cream uses a person's own blood components, which requires preparation and may not be widely available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

20 people

The number who actually took part.

Started

Feb 2022

Finished

Feb 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 40 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * healthy volunteers with healthy skin, who sign an agreement for study participation Exclusion Criteria: * systemic diseases, smoking, blood disorders, acute viral infections and skin inflammations, pregnancy, and breastfeeding.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Skin ageing are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Skin ageing

Contacts and locations

Locations

  • Poznan University of Medical Sciences

    Poznan, The Greater Poland, 60-812, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.